Listed

Co-Diagnostics, Inc.

CODXNasdaqCIK 1692415HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last eight fiscal years. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$622.5k, FY2025
Operating income−$50.2m, FY2025
Net income−$46.9m, FY2025
Co-Diagnostics, Inc., income statement, annual
Line itemUnitFY20182018-12-31FY20192019-12-31FY20202020-12-31FY20212021-12-31FY20222022-12-31FY20232023-12-31FY20242024-12-31FY20252025-12-31
Revenue$m0.0Revenue, FY2018, twelve months to 2018-12-31$39.9k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2020-03-30, accession 0001493152-20-005305.Report this figure0.2Revenue, FY2019, twelve months to 2019-12-31$215.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2021-03-25, accession 0001493152-21-006810.Report this figure74.6Revenue, FY2020, twelve months to 2020-12-31$74.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2022-03-24, accession 0001493152-22-007662.Report this figure97.9Revenue, FY2021, twelve months to 2021-12-31$97.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2023-03-16, accession 0001493152-23-007925.Report this figure34.2Revenue, FY2022, twelve months to 2022-12-31$34.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-03-14, accession 0001493152-24-009955.Report this figure6.8Revenue, FY2023, twelve months to 2023-12-31$6.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-27, accession 0001641172-25-000932.Report this figure3.9Revenue, FY2024, twelve months to 2024-12-31$3.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-31, accession 0001493152-26-014158.Report this figure0.6Revenue, FY2025, twelve months to 2025-12-31$622.5k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-31, accession 0001493152-26-014158.Report this figure
Cost of revenue$m0.0Cost of revenue, FY2018, twelve months to 2018-12-31$9.4k. XBRL concept us-gaap:CostOfRevenue. 10-K filed 2020-03-30, accession 0001493152-20-005305.Report this figure0.1Cost of revenue, FY2019, twelve months to 2019-12-31$112.4k. XBRL concept us-gaap:CostOfRevenue. 10-K filed 2021-03-25, accession 0001493152-21-006810.Report this figure16.6Cost of revenue, FY2020, twelve months to 2020-12-31$16.6m. XBRL concept us-gaap:CostOfRevenue. 10-K filed 2022-03-24, accession 0001493152-22-007662.Report this figure11.6Cost of revenue, FY2021, twelve months to 2021-12-31$11.6m. XBRL concept us-gaap:CostOfRevenue. 10-K filed 2023-03-16, accession 0001493152-23-007925.Report this figure5.5Cost of revenue, FY2022, twelve months to 2022-12-31$5.5m. XBRL concept us-gaap:CostOfRevenue. 10-K filed 2024-03-14, accession 0001493152-24-009955.Report this figure4.2Cost of revenue, FY2023, twelve months to 2023-12-31$4.2m. XBRL concept us-gaap:CostOfRevenue. 10-K filed 2025-03-27, accession 0001641172-25-000932.Report this figure1.0Cost of revenue, FY2024, twelve months to 2024-12-31$999.1k. XBRL concept us-gaap:CostOfRevenue. 10-K filed 2026-03-31, accession 0001493152-26-014158.Report this figure0.2Cost of revenue, FY2025, twelve months to 2025-12-31$222.4k. XBRL concept us-gaap:CostOfRevenue. 10-K filed 2026-03-31, accession 0001493152-26-014158.Report this figure
Gross profit$m0.0Gross profit, FY2018, twelve months to 2018-12-31$30.5k. XBRL concept us-gaap:GrossProfit. 10-K filed 2020-03-30, accession 0001493152-20-005305.Report this figure0.1Gross profit, FY2019, twelve months to 2019-12-31$102.5k. XBRL concept us-gaap:GrossProfit. 10-K filed 2021-03-25, accession 0001493152-21-006810.Report this figure58.0Gross profit, FY2020, twelve months to 2020-12-31$58.0m. XBRL concept us-gaap:GrossProfit. 10-K filed 2022-03-24, accession 0001493152-22-007662.Report this figure86.3Gross profit, FY2021, twelve months to 2021-12-31$86.3m. XBRL concept us-gaap:GrossProfit. 10-K filed 2023-03-16, accession 0001493152-23-007925.Report this figure28.7Gross profit, FY2022, twelve months to 2022-12-31$28.7m. XBRL concept us-gaap:GrossProfit. 10-K filed 2024-03-14, accession 0001493152-24-009955.Report this figure2.6Gross profit, FY2023, twelve months to 2023-12-31$2.6m. XBRL concept us-gaap:GrossProfit. 10-K filed 2025-03-27, accession 0001641172-25-000932.Report this figure2.9Gross profit, FY2024, twelve months to 2024-12-31$2.9m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-31, accession 0001493152-26-014158.Report this figure0.4Gross profit, FY2025, twelve months to 2025-12-31$400.1k. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-31, accession 0001493152-26-014158.Report this figure
Research and development$m1.4Research and development, FY2018, twelve months to 2018-12-31$1.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2020-03-30, accession 0001493152-20-005305.Report this figure1.4Research and development, FY2019, twelve months to 2019-12-31$1.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2021-03-25, accession 0001493152-21-006810.Report this figure3.2Research and development, FY2020, twelve months to 2020-12-31$3.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2022-03-24, accession 0001493152-22-007662.Report this figure15.0Research and development, FY2021, twelve months to 2021-12-31$15.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2023-03-16, accession 0001493152-23-007925.Report this figure17.4Research and development, FY2022, twelve months to 2022-12-31$17.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2024-03-14, accession 0001493152-24-009955.Report this figure23.0Research and development, FY2023, twelve months to 2023-12-31$23.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-27, accession 0001641172-25-000932.Report this figure21.0Research and development, FY2024, twelve months to 2024-12-31$21.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-31, accession 0001493152-26-014158.Report this figure19.1Research and development, FY2025, twelve months to 2025-12-31$19.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-31, accession 0001493152-26-014158.Report this figure
Operating income$m(6.1)Operating income, FY2018, twelve months to 2018-12-31−$6.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2020-03-30, accession 0001493152-20-005305.Report this figure(5.9)Operating income, FY2019, twelve months to 2019-12-31−$5.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2021-03-25, accession 0001493152-21-006810.Report this figure41.7Operating income, FY2020, twelve months to 2020-12-31$41.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2022-03-24, accession 0001493152-22-007662.Report this figure46.1Operating income, FY2021, twelve months to 2021-12-31$46.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2023-03-16, accession 0001493152-23-007925.Report this figure(27.0)Operating income, FY2022, twelve months to 2022-12-31−$27.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2024-03-14, accession 0001493152-24-009955.Report this figure(42.7)Operating income, FY2023, twelve months to 2023-12-31−$42.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-27, accession 0001641172-25-000932.Report this figure(40.1)Operating income, FY2024, twelve months to 2024-12-31−$40.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-31, accession 0001493152-26-014158.Report this figure(50.2)Operating income, FY2025, twelve months to 2025-12-31−$50.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-31, accession 0001493152-26-014158.Report this figure
Interest expense$mnot reported0.1Interest expense, FY2019, twelve months to 2019-12-31$106.4k. XBRL concept us-gaap:InterestExpense. 10-K filed 2021-03-25, accession 0001493152-21-006810.Report this figurenot reportednot reportednot reportednot reportednot reportednot reported
Income tax$mnot reportednot reported0.1Income tax, FY2020, twelve months to 2020-12-31$90.5k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2022-03-24, accession 0001493152-22-007662.Report this figure9.0Income tax, FY2021, twelve months to 2021-12-31$9.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2023-03-16, accession 0001493152-23-007925.Report this figure(4.6)Income tax, FY2022, twelve months to 2022-12-31−$4.6m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2024-03-14, accession 0001493152-24-009955.Report this figure(2.8)Income tax, FY2023, twelve months to 2023-12-31−$2.8m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2025-03-27, accession 0001641172-25-000932.Report this figure0.1Income tax, FY2024, twelve months to 2024-12-31$57.4k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-31, accession 0001493152-26-014158.Report this figure(1.6)Income tax, FY2025, twelve months to 2025-12-31−$1.6m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-31, accession 0001493152-26-014158.Report this figure
Net income$m(6.3)Net income, FY2018, twelve months to 2018-12-31−$6.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2020-03-30, accession 0001493152-20-005305.Report this figure(6.2)Net income, FY2019, twelve months to 2019-12-31−$6.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2021-03-25, accession 0001493152-21-006810.Report this figure42.5Net income, FY2020, twelve months to 2020-12-31$42.5m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2022-03-24, accession 0001493152-22-007662.Report this figure36.7Net income, FY2021, twelve months to 2021-12-31$36.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2023-03-16, accession 0001493152-23-007925.Report this figure(14.2)Net income, FY2022, twelve months to 2022-12-31−$14.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2024-03-14, accession 0001493152-24-009955.Report this figure(35.3)Net income, FY2023, twelve months to 2023-12-31−$35.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-27, accession 0001641172-25-000932.Report this figure(37.6)Net income, FY2024, twelve months to 2024-12-31−$37.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-31, accession 0001493152-26-014158.Report this figure(46.9)Net income, FY2025, twelve months to 2025-12-31−$46.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-31, accession 0001493152-26-014158.Report this figure
Diluted EPS$ per share(0.50)Diluted EPS, FY2018, twelve months to 2018-12-31−$0.50 per share. XBRL concept us-gaap:EarningsPerShareBasicAndDiluted. 10-K filed 2020-03-30, accession 0001493152-20-005305.Report this figure(0.37)Diluted EPS, FY2019, twelve months to 2019-12-31−$0.37 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2021-03-25, accession 0001493152-21-006810.Report this figure1.52Diluted EPS, FY2020, twelve months to 2020-12-31$1.52 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2022-03-24, accession 0001493152-22-007662.Report this figure1.23Diluted EPS, FY2021, twelve months to 2021-12-31$1.23 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2023-03-16, accession 0001493152-23-007925.Report this figure(0.45)Diluted EPS, FY2022, twelve months to 2022-12-31−$0.45 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2024-03-14, accession 0001493152-24-009955.Report this figure(1.20)Diluted EPS, FY2023, twelve months to 2023-12-31−$1.20 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2025-03-27, accession 0001641172-25-000932.Report this figure(37.22)Diluted EPS, FY2024, twelve months to 2024-12-31−$37.22 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-03-31, accession 0001493152-26-014158.Report this figure(35.25)Diluted EPS, FY2025, twelve months to 2025-12-31−$35.25 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-03-31, accession 0001493152-26-014158.Report this figure
Basic EPS$ per sharenot reported(0.37)Basic EPS, FY2019, twelve months to 2019-12-31−$0.37 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-K filed 2021-03-25, accession 0001493152-21-006810.Report this figure1.59Basic EPS, FY2020, twelve months to 2020-12-31$1.59 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-K filed 2022-03-24, accession 0001493152-22-007662.Report this figure1.27Basic EPS, FY2021, twelve months to 2021-12-31$1.27 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-K filed 2023-03-16, accession 0001493152-23-007925.Report this figure(0.45)Basic EPS, FY2022, twelve months to 2022-12-31−$0.45 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-K filed 2024-03-14, accession 0001493152-24-009955.Report this figure(1.20)Basic EPS, FY2023, twelve months to 2023-12-31−$1.20 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-K filed 2025-03-27, accession 0001641172-25-000932.Report this figure(37.22)Basic EPS, FY2024, twelve months to 2024-12-31−$37.22 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-K filed 2026-03-31, accession 0001493152-26-014158.Report this figure(35.25)Basic EPS, FY2025, twelve months to 2025-12-31−$35.25 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-K filed 2026-03-31, accession 0001493152-26-014158.Report this figure

Balance sheet

Cash and equivalents$11.9m, FY2025
Long-term debt$1.9m, FY2018
Shareholders' equity$20.6m, FY2025
Co-Diagnostics, Inc., balance sheet, annual
Line itemUnitFY20182018-12-31FY20192019-12-31FY20202020-12-31FY20212021-12-31FY20222022-12-31FY20232023-12-31FY20242024-12-31FY20252025-12-31
Cash and equivalents$m1.0Cash and equivalents, FY2018, at 2018-12-31$950.2k. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2020-03-30, accession 0001493152-20-005305.Report this figure0.9Cash and equivalents, FY2019, at 2019-12-31$893.1k. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2021-03-25, accession 0001493152-21-006810.Report this figure43.0Cash and equivalents, FY2020, at 2020-12-31$43.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2022-03-24, accession 0001493152-22-007662.Report this figure88.6Cash and equivalents, FY2021, at 2021-12-31$88.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2023-03-16, accession 0001493152-23-007925.Report this figure23.0Cash and equivalents, FY2022, at 2022-12-31$23.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2024-03-14, accession 0001493152-24-009955.Report this figure14.9Cash and equivalents, FY2023, at 2023-12-31$14.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-27, accession 0001641172-25-000932.Report this figure2.9Cash and equivalents, FY2024, at 2024-12-31$2.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-31, accession 0001493152-26-014158.Report this figure11.9Cash and equivalents, FY2025, at 2025-12-31$11.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-13, accession 0001493152-26-037762.Report this figure
Current assets$m1.1Current assets, FY2018, at 2018-12-31$1.1m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2020-03-30, accession 0001493152-20-005305.Report this figure1.6Current assets, FY2019, at 2019-12-31$1.6m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2021-03-25, accession 0001493152-21-006810.Report this figure67.8Current assets, FY2020, at 2020-12-31$67.8m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2022-03-24, accession 0001493152-22-007662.Report this figure115Current assets, FY2021, at 2021-12-31$115.1m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2023-03-16, accession 0001493152-23-007925.Report this figure92.7Current assets, FY2022, at 2022-12-31$92.7m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2024-03-14, accession 0001493152-24-009955.Report this figure62.1Current assets, FY2023, at 2023-12-31$62.1m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-27, accession 0001641172-25-000932.Report this figure32.3Current assets, FY2024, at 2024-12-31$32.3m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-31, accession 0001493152-26-014158.Report this figure13.7Current assets, FY2025, at 2025-12-31$13.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-13, accession 0001493152-26-037762.Report this figure
Total assets$m1.6Total assets, FY2018, at 2018-12-31$1.6m. XBRL concept us-gaap:Assets. 10-K filed 2020-03-30, accession 0001493152-20-005305.Report this figure2.2Total assets, FY2019, at 2019-12-31$2.2m. XBRL concept us-gaap:Assets. 10-K filed 2021-03-25, accession 0001493152-21-006810.Report this figure71.2Total assets, FY2020, at 2020-12-31$71.2m. XBRL concept us-gaap:Assets. 10-K filed 2022-03-24, accession 0001493152-22-007662.Report this figure160Total assets, FY2021, at 2021-12-31$160.0m. XBRL concept us-gaap:Assets. 10-K filed 2023-03-16, accession 0001493152-23-007925.Report this figure123Total assets, FY2022, at 2022-12-31$123.1m. XBRL concept us-gaap:Assets. 10-K filed 2024-03-14, accession 0001493152-24-009955.Report this figure95.3Total assets, FY2023, at 2023-12-31$95.3m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-27, accession 0001641172-25-000932.Report this figure63.6Total assets, FY2024, at 2024-12-31$63.6m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-31, accession 0001493152-26-014158.Report this figure24.7Total assets, FY2025, at 2025-12-31$24.7m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-13, accession 0001493152-26-037762.Report this figure
Current liabilities$m2.4Current liabilities, FY2018, at 2018-12-31$2.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2020-03-30, accession 0001493152-20-005305.Report this figure0.3Current liabilities, FY2019, at 2019-12-31$328.1k. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2021-03-25, accession 0001493152-21-006810.Report this figure4.1Current liabilities, FY2020, at 2020-12-31$4.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2022-03-24, accession 0001493152-22-007662.Report this figure12.6Current liabilities, FY2021, at 2021-12-31$12.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2023-03-16, accession 0001493152-23-007925.Report this figure3.9Current liabilities, FY2022, at 2022-12-31$3.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2024-03-14, accession 0001493152-24-009955.Report this figure5.7Current liabilities, FY2023, at 2023-12-31$5.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-27, accession 0001641172-25-000932.Report this figure7.3Current liabilities, FY2024, at 2024-12-31$7.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-31, accession 0001493152-26-014158.Report this figure3.5Current liabilities, FY2025, at 2025-12-31$3.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-13, accession 0001493152-26-037762.Report this figure
Total liabilities$m2.6Total liabilities, FY2018, at 2018-12-31$2.6m. XBRL concept us-gaap:Liabilities. 10-K filed 2020-03-30, accession 0001493152-20-005305.Report this figure0.5Total liabilities, FY2019, at 2019-12-31$478.1k. XBRL concept us-gaap:Liabilities. 10-K filed 2021-03-25, accession 0001493152-21-006810.Report this figure4.5Total liabilities, FY2020, at 2020-12-31$4.5m. XBRL concept us-gaap:Liabilities. 10-K filed 2022-03-24, accession 0001493152-22-007662.Report this figure25.6Total liabilities, FY2021, at 2021-12-31$25.6m. XBRL concept us-gaap:Liabilities. 10-K filed 2023-03-16, accession 0001493152-23-007925.Report this figure8.6Total liabilities, FY2022, at 2022-12-31$8.6m. XBRL concept us-gaap:Liabilities. 10-K filed 2024-03-14, accession 0001493152-24-009955.Report this figure9.3Total liabilities, FY2023, at 2023-12-31$9.3m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-27, accession 0001641172-25-000932.Report this figure9.7Total liabilities, FY2024, at 2024-12-31$9.7m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-31, accession 0001493152-26-014158.Report this figure4.1Total liabilities, FY2025, at 2025-12-31$4.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-13, accession 0001493152-26-037762.Report this figure
Long-term debt$m1.9Long-term debt, FY2018, at 2018-12-31$1.9m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2020-03-30, accession 0001493152-20-005305.Report this figurenot reportednot reportednot reportednot reportednot reportednot reportednot reported
Current portion of debt$m1.9Current portion of debt, FY2018, at 2018-12-31$1.9m. XBRL concept us-gaap:LongTermDebtCurrent. 10-K filed 2020-03-30, accession 0001493152-20-005305.Report this figurenot reportednot reportednot reportednot reportednot reportednot reportednot reported
Shareholders' equity$m(1.1)Shareholders' equity, FY2018, at 2018-12-31−$1.1m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2021-03-25, accession 0001493152-21-006810.Report this figure1.7Shareholders' equity, FY2019, at 2019-12-31$1.7m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2022-03-24, accession 0001493152-22-007662.Report this figure66.7Shareholders' equity, FY2020, at 2020-12-31$66.7m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2023-03-16, accession 0001493152-23-007925.Report this figure134Shareholders' equity, FY2021, at 2021-12-31$134.5m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2024-03-14, accession 0001493152-24-009955.Report this figure115Shareholders' equity, FY2022, at 2022-12-31$114.5m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2025-03-27, accession 0001641172-25-000932.Report this figure85.6Shareholders' equity, FY2023, at 2023-12-31$85.6m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-31, accession 0001493152-26-014158.Report this figure53.9Shareholders' equity, FY2024, at 2024-12-31$53.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001493152-26-037762.Report this figure20.6Shareholders' equity, FY2025, at 2025-12-31$20.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001493152-26-037762.Report this figure

Cash flow

Operating cash flow−$29.1m, FY2025
Capital expenditure$700.0k, FY2025
Share repurchases$1.4m, FY2023
Co-Diagnostics, Inc., cash flow, annual
Line itemUnitFY20182018-12-31FY20192019-12-31FY20202020-12-31FY20212021-12-31FY20222022-12-31FY20232023-12-31FY20242024-12-31FY20252025-12-31
Operating cash flow$m(4.1)Operating cash flow, FY2018, twelve months to 2018-12-31−$4.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2020-03-30, accession 0001493152-20-005305.Report this figure(5.5)Operating cash flow, FY2019, twelve months to 2019-12-31−$5.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2021-03-25, accession 0001493152-21-006810.Report this figure28.2Operating cash flow, FY2020, twelve months to 2020-12-31$28.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2022-03-24, accession 0001493152-22-007662.Report this figure41.1Operating cash flow, FY2021, twelve months to 2021-12-31$41.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2023-03-16, accession 0001493152-23-007925.Report this figure6.6Operating cash flow, FY2022, twelve months to 2022-12-31$6.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2024-03-14, accession 0001493152-24-009955.Report this figure(22.1)Operating cash flow, FY2023, twelve months to 2023-12-31−$22.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-27, accession 0001641172-25-000932.Report this figure(29.2)Operating cash flow, FY2024, twelve months to 2024-12-31−$29.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-31, accession 0001493152-26-014158.Report this figure(29.1)Operating cash flow, FY2025, twelve months to 2025-12-31−$29.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-31, accession 0001493152-26-014158.Report this figure
Capital expenditure$m0.0Capital expenditure, FY2018, twelve months to 2018-12-31$41.3k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2020-03-30, accession 0001493152-20-005305.Report this figure0.1Capital expenditure, FY2019, twelve months to 2019-12-31$113.2k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2021-03-25, accession 0001493152-21-006810.Report this figure0.8Capital expenditure, FY2020, twelve months to 2020-12-31$774.4k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2022-03-24, accession 0001493152-22-007662.Report this figure0.7Capital expenditure, FY2021, twelve months to 2021-12-31$669.5k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2023-03-16, accession 0001493152-23-007925.Report this figure1.4Capital expenditure, FY2022, twelve months to 2022-12-31$1.4m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2024-03-14, accession 0001493152-24-009955.Report this figure1.4Capital expenditure, FY2023, twelve months to 2023-12-31$1.4m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-27, accession 0001641172-25-000932.Report this figure0.7Capital expenditure, FY2024, twelve months to 2024-12-31$748.4k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-31, accession 0001493152-26-014158.Report this figure0.7Capital expenditure, FY2025, twelve months to 2025-12-31$700.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-31, accession 0001493152-26-014158.Report this figure
Share repurchases$mnot reportednot reportednot reportednot reported14.2Share repurchases, FY2022, twelve months to 2022-12-31$14.2m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2024-03-14, accession 0001493152-24-009955.Report this figure1.4Share repurchases, FY2023, twelve months to 2023-12-31$1.4m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2025-03-27, accession 0001641172-25-000932.Report this figurenot reportednot reported

Shares

Diluted shares (weighted)1.33m, FY2025
Co-Diagnostics, Inc., shares, annual
Line itemUnitFY20192019-12-31FY20202020-12-31FY20212021-12-31FY20222022-12-31FY20232023-12-31FY20242024-12-31FY20252025-12-31
Diluted shares (weighted)m shares16.8Diluted shares (weighted), FY2019, twelve months to 2019-12-3116,756,912 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-K filed 2021-03-25, accession 0001493152-21-006810.Report this figure28.0Diluted shares (weighted), FY2020, twelve months to 2020-12-3128,000,341 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-K filed 2022-03-24, accession 0001493152-22-007662.Report this figure29.9Diluted shares (weighted), FY2021, twelve months to 2021-12-3129,903,686 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-K filed 2023-03-16, accession 0001493152-23-007925.Report this figure31.5Diluted shares (weighted), FY2022, twelve months to 2022-12-3131,479,028 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-K filed 2024-03-14, accession 0001493152-24-009955.Report this figure29.3Diluted shares (weighted), FY2023, twelve months to 2023-12-3129,346,599 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-K filed 2025-03-27, accession 0001641172-25-000932.Report this figure1.0Diluted shares (weighted), FY2024, twelve months to 2024-12-311,011,179 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-K filed 2026-03-31, accession 0001493152-26-014158.Report this figure1.3Diluted shares (weighted), FY2025, twelve months to 2025-12-311,330,200 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-K filed 2026-03-31, accession 0001493152-26-014158.Report this figure

Shares outstanding: 6.25mShares outstanding, period not labelled, at 2026-08-116,252,319 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-13, accession 0001493152-26-037762.Report this figure at Aug 11, 2026, from the cover of the 10-Q filed Aug 13, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:46 ET. Listed shows no prices and gives no investment advice.